OSCCs are divided into “non-T cell-inflamed cancers” (low-density inflammatory infiltrate, decreased HLA expression, and low-level IFN-γ expression in TILs) and “T cell-inflamed cancers” (with the opposite characteristics). This evidence concerns the gene IFNG and cancer.